Jubilant Generics invests Rs 20 lakh in Jubilant Pharma Canada

Ruchika Sharma

Jubilant Generics invests Rs 20 lakh in Jubilant Pharma Canada

Written By : Ruchika Sharma Published On 2025-12-31T14:47:39+05:30 | Updated On 31 Dec 2025 2:47 PM IST

Noida: Jubilant Pharmova has announced that Jubilant Generics, a step-down wholly owned subsidiary of the Company, has made an investment of approx..Rs 0.20 crores in Jubilant Pharmaceuticals Inc., Canada.

Following the initial investment, Jubilant Pharmaceuticals Inc. has become a step-down wholly owned subsidiary of the Company.

The company said this transaction is aimed at establishing a branded generics business in Canada, strengthening Jubilant’s presence in the Canadian market, and resulting in revenue growth.

As part of the transaction, Jubilant Generics has made an initial investment of CAD 30,000 (approximately ₹0.20 crore) to subscribe to 30,000 shares of common stock.

Jubilant Pharmova Limited, formerly Jubilant Life Sciences Limited, is a company with a global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.

In the Radiopharma business, the Company is involved in the manufacturing and supply of Radiopharmaceuticals with a network of 45 radiopharmacies in the US.

The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia.

Jubilant Pharmova Limited through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules. The CRDMO business of the Company includes the Drug Discovery Services business that provides contract research and development services through two world-class research centers in Bengaluru and Noida in India and one in France.

The CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics is involved in the Proprietary Novel Drugs business and is an innovative biopharmaceutical company developing breakthrough therapies in the area of oncology and autoimmune disorders. The Company operates multiple manufacturing facilities that cater to all the regulated markets including USA, Europe and other geographies.

jubilant pharmovajubilant genericsinvestmentjubilant pharma canada

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751